BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30982352)

  • 21. MiR-5692a promotes proliferation and inhibits apoptosis by targeting HOXD8 in hepatocellular carcinoma.
    Sun S; Wang N; Sun Z; Wang X; Cui H
    J BUON; 2019; 24(1):178-186. PubMed ID: 30941968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
    Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
    Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X; Gao Y; Qin J; Lu S
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA 657 suppresses hepatocellular carcinoma cell growth by acting as a molecular sponge of miR-106a-5p to regulate PTEN expression.
    Hu B; Cai H; Zheng R; Yang S; Zhou Z; Tu J
    Int J Biochem Cell Biol; 2017 Nov; 92():34-42. PubMed ID: 28919047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.
    Jiang X; Shen X
    Bull Cancer; 2018 Oct; 105(10):873-883. PubMed ID: 30266288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-199a-5p suppresses tumorigenesis by targeting clathrin heavy chain in hepatocellular carcinoma.
    Huang GH; Shan H; Li D; Zhou B; Pang PF
    Cell Biochem Funct; 2017 Mar; 35(2):98-104. PubMed ID: 28261837
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway.
    Lou G; Dong X; Xia C; Ye B; Yan Q; Wu S; Yu Y; Liu F; Zheng M; Chen Z; Liu Y
    J Exp Clin Cancer Res; 2016 Jan; 35():14. PubMed ID: 26790956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-137 suppresses migration and invasion by targeting EZH2-STAT3 signaling in human hepatocellular carcinoma.
    Huang B; Huang M; Li Q
    Pathol Res Pract; 2018 Dec; 214(12):1980-1986. PubMed ID: 30274685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Over-expression of Thrombospondin 4 correlates with loss of miR-142 and contributes to migration and vascular invasion of advanced hepatocellular carcinoma.
    Su F; Zhao J; Qin S; Wang R; Li Y; Wang Q; Tan Y; Jin H; Zhu F; Ou Y; Cheng Z; Su W; Zhao F; Yang Y; Zhou Z; Zheng J; Li Y; Li Z; Wu Q
    Oncotarget; 2017 Apr; 8(14):23277-23288. PubMed ID: 28177895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NEAT1 promotes cell proliferation and invasion in hepatocellular carcinoma by negative regulating miR-613 expression.
    Wang Z; Zou Q; Song M; Chen J
    Biomed Pharmacother; 2017 Oct; 94():612-618. PubMed ID: 28783584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of microRNA-718, a new regulator of EGR3, in regulation of malignant phenotype of HCC cells.
    Wang ZD; Qu FY; Chen YY; Ran ZS; Liu HY; Zhang HD
    J Zhejiang Univ Sci B; 2017 Jan.; 18(1):27-36. PubMed ID: 28070994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-199b exerts tumor suppressive functions in hepatocellular carcinoma by directly targeting JAG1.
    Li GL; Yuan JH; Zhuang GD; Wu DQ
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7679-7687. PubMed ID: 30536310
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-299-3p functions as a tumor suppressor via targeting Sirtuin 5 in hepatocellular carcinoma.
    Dang S; Zhou J; Wang Z; Wang K; Dai S; He S
    Biomed Pharmacother; 2018 Oct; 106():966-975. PubMed ID: 30170358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
    Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
    J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-383 inhibits hepatocellular carcinoma cell proliferation via targeting APRIL.
    Chen L; Guan H; Gu C; Cao Y; Shao J; Wang F
    Tumour Biol; 2016 Feb; 37(2):2497-507. PubMed ID: 26385772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
    Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.